2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance map** of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …
Parametric map** techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport …
Myocardial diseases are associated with an increased risk of potentially fatal cardiac
arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic …
arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic …
T1 map**: basic techniques and clinical applications
In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
S Neubauer, P Kolm, CY Ho, RY Kwong… - Journal of the American …, 2019 - jacc.org
Abstract Background: The HCMR (Hypertrophic Cardiomyopathy Registry) is a National
Heart, Lung, and Blood Institute–funded, prospective registry of 2,755 patients with …
Heart, Lung, and Blood Institute–funded, prospective registry of 2,755 patients with …
Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy
Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …
T1 map** in characterizing myocardial disease: a comprehensive review
VO Puntmann, E Peker, Y Chandrashekhar… - Circulation …, 2016 - Am Heart Assoc
Cardiovascular magnetic resonance provides insights into myocardial structure and function
noninvasively, with high diagnostic accuracy and without ionizing radiation. Myocardial …
noninvasively, with high diagnostic accuracy and without ionizing radiation. Myocardial …
Myocardial tissue characterization and fibrosis by imaging
Myocardial fibrosis, either focal or diffuse, is a common feature of many cardiac diseases
and is associated with a poor prognosis for major adverse cardiovascular events. Although …
and is associated with a poor prognosis for major adverse cardiovascular events. Although …
Myocardial T1 and T2 map**: techniques and clinical applications
Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …
Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure
T Liu, D Song, J Dong, P Zhu, J Liu, W Liu, X Ma… - Frontiers in …, 2017 - frontiersin.org
Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and
death. Myocardial fibrosis results from increased myofibroblast activity and excessive …
death. Myocardial fibrosis results from increased myofibroblast activity and excessive …